2023, April 20 – Free VetMedTeam Webinar
April 20 @ 4:00 pm - 5:00 pm PDT
FREEWebinar
How the “Blood Test for Cancer” Performs in the Real World: An Analysis of 1,500 Liquid Biopsy Cases
Blood-based liquid biopsy using next-generation sequencing (NGS) became clinically available in May 2021. Since that time, the test has been ordered for thousands of patients, primarily as a screening tool for dogs at higher risk of cancer as well as an aid in diagnosis for dogs for which there is a clinical suspicion of cancer.
Join Todd Cohen, DVM, DACVIM (Small Animal Internal Medicine), for a review of data from a recent publication in the Journal of the American Veterinary Medical Association (JAVMA) analyzing a cohort of 1,500 consecutive liquid biopsy tests received for commercial testing at one clinical laboratory. The webinar will include a discussion of ordering patterns, positivity rates, and patient outcome data, along with how this data can be used to discuss liquid biopsy testing with clients. A series of interesting case studies will be presented, exploring the use of this testing in a variety of clinical settings.
This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.